Both in Pharmaceuticals
Summit Therapeutics vs Spyre Therapeutics
Over the past year SMMT returned −13.3% and SYRE returned +317.5%; their daily moves had a correlation of 0.33.
SMMT −13.3% SYRE +317.5%Growth of $1, one year, split-adjusted
| Metric | SMMT | SYRE |
|---|---|---|
| Price | $15.80 | $99.27 |
| Market cap | $12.60B | $9.28B |
| Today | +6.76% | +3.94% |
| 1 month | −8.5% | +7.1% |
| 6 months | −9.9% | +39.8% |
| Year to date | −9.7% | +203.0% |
| 1 year | −16.4% | +305.8% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $690.7M | $1.15B |
| Dividend yield | — | — |
| Volatility (60d) | 70.7% | 59.2% |
| Short % of float | 29.5% | 15.6% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).